Efficacy of PIMUN by Reducing Intermittent Hypoxia Events
Clinical Study of Intermittent Hypoxia Reduction Using PIMUN: Efficacy Proof-of-Concept
Pontificia Universidad Catolica de Chile
20 participants
Sep 1, 2024
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to learn if the use of PIMUN(medical device) works to reduce the intermittent hypoxemia of 24-34 weeks of birth gestational age babies. . It will also learn about the safety of the use of PIMUN. The main questions it aims to answer are: Does PIMUN lower the time of oxygen saturation under 90%? What medical problems do participants have using PIMUN? Researchers will compare the use of PIMUN during 48 hours to 48 hours of usual treatments (not using PIMUN). Participants will: Use/ or not use of PIMUN for a 48 hours period- randomly assigned. Regional brain oxygenation by near infrared spectroscopy (NIRS) monitoring at the first day of each 48 hours period. 4-6 hours of polysomnography at the second day of each intervention. Plasma and urine stress oxygen metabolites at the end of each 48-hours intervention.
Eligibility
Inclusion Criteria3
- Preterm infants with a gestational age at birth \<34 weeks
- Age \<30 days at the time of enrollment
- Documented diagnosis of apnea of prematurity (AOP)
Exclusion Criteria6
- Currently receiving mechanical ventilation (MV)
- Presence of major congenital malformations
- Clinically unstable or critically ill at the time of screening
- Active sepsis or undergoing treatment for sepsis
- Intraventricular hemorrhage (IVH) Grade \> II
- Receiving sedatives or anticonvulsant medications
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
24 hours of Brain regional oxygen saturation by NIRS
4-5 hours of polysomnogram recording
Blood and urine samples to detect plasma not albumin bound proteins- neuroprostane and isoflurane
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07396103